ARTICLE | Company News
AVE to evaluate QIA's microarray technology
June 28, 2001 7:00 AM UTC
Qiagen (NMarkt:QIA; QGENF) granted Aventis (AVE) limited access to evaluate its ZeptoGene Workstation technology platform. QIA's technology, developed with Zeptosens (Witterswil, Switzerland), is base...